Lipoprotein(a) and Coronary Heart Disease: Meta-Analysis of Prospective Studies
暂无分享,去创建一个
[1] M. Koschinsky,et al. Lipoprotein(a) concentration and apolipoprotein(a) size: A synergistic role in advanced atherosclerosis? , 1999, Circulation.
[2] F. Kronenberg,et al. Role of lipoprotein(a) and apolipoprotein(a) phenotype in atherogenesis: prospective results from the Bruneck study. , 1999, Circulation.
[3] R. Collins,et al. Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. , 1999, American journal of epidemiology.
[4] S. Watanabe,et al. Lipoprotein(a) as a risk factor for coronary artery disease in hemodialysis patients. , 1999, Kidney international. Supplement.
[5] A. Moss,et al. Thrombogenic factors and recurrent coronary events. , 1999, Circulation.
[6] P. Fratino,et al. Association between apolipoprotein(a) phenotypes and coronary heart disease at a young age. , 1999, Journal of the American College of Cardiology.
[7] M. Koschinsky,et al. Lipoprotein(a) as a risk factor for coronary artery disease. , 1998, The American journal of cardiology.
[8] J. Shepherd. Preventing coronary artery disease in the West of Scotland: implications for primary prevention. , 1998, The American journal of cardiology.
[9] Stenlund,et al. Lipoprotein(a) and cholesterol levels act synergistically and apolipoprotein A‐I is protective for the incidence of primary acute myocardial infarction in middle‐aged males. An incident case–control study from Sweden , 1998, Journal of internal medicine.
[10] J. Haddow,et al. Lipoprotein(a) as a risk factor for ischemic heart disease: metaanalysis of prospective studies. , 1998, Clinical chemistry.
[11] D. Lane,et al. Lipoprotein(a) as a risk predictor for cardiac mortality in patients with acute coronary syndromes. , 1998, European heart journal.
[12] R Peto,et al. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. , 1998, JAMA.
[13] L. Wilhelmsen,et al. Serum lipids, lipoprotein(a) and apo(a) isoforms in patients with established coronary artery disease and their relation to disease and prognosis after coronary by-pass surgery. , 1998, Atherosclerosis.
[14] G. Dagenais,et al. Is lipoprotein(a) an independent risk factor for ischemic heart disease in men? The Quebec Cardiovascular Study. , 1998, Journal of the American College of Cardiology.
[15] E. Wall,et al. Gated SPECT radionuclide angiography: what is the gain? , 1998 .
[16] J. Kjekshus,et al. Lp(a) lipoprotein level predicts survival and major coronary events in the Scandinavian Simvastatin Survival Study , 1997, Clinical genetics.
[17] K. Bailey,et al. Predictive value of electrophoretically detected lipoprotein(a) for coronary heart disease and cerebrovascular disease in a community-based cohort of 9936 men and women. , 1997, Circulation.
[18] M. Farrer,et al. Serum Lp(a) lipoprotein concentration is not associated with clinical and angiographic outcome five years after coronary artery bypass graft surgery. , 1997, Heart.
[19] M. Schroll,et al. Apolipoprotein(a) isoforms and coronary heart disease in men: a nested case-control study. , 1997, Atherosclerosis.
[20] D. Nagel,et al. Ten-year follow-up results from the Goettingen Risk, Incidence and Prevalence Study (GRIPS). I. Risk factors for myocardial infarction in a cohort of 5790 men. , 1997, Atherosclerosis.
[21] S. Fortmann,et al. A prospective case-control study of lipoprotein(a) levels and apo(a) size and risk of coronary heart disease in Stanford Five-City Project participants. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[22] F. Kronenberg,et al. Lipoprotein(a) in stored plasma samples and the ravages of time. Why epidemiological studies might fail. , 1996, Arteriosclerosis, thrombosis, and vascular biology.
[23] P. Wilson,et al. Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study. , 1996, JAMA.
[24] A. von Eckardstein,et al. Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men. , 1996, The American journal of cardiology.
[25] B. G. Brown,et al. Effects of lowering elevated LDL cholesterol on the cardiovascular risk of lipoprotein(a). , 1995, JAMA.
[26] P. Wilson,et al. A prospective investigation of elevated lipoprotein (a) detected by electrophoresis and cardiovascular disease in women. The Framingham Heart Study. , 1994, Circulation.
[27] M. Mittleman,et al. Lipoprotein(a) in coronary heart disease. Is it a risk factor after all? , 1994, JAMA.
[28] J. Ordovás,et al. Lipoprotein(a) levels and risk of coronary heart disease in men. The lipid Research Clinics Coronary Primary Prevention Trial. , 1994, JAMA.
[29] J. Salonen,et al. Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study. , 1994, Atherosclerosis.
[30] N. Wald,et al. Apolipoproteins and ischaemic heart disease: implications for screening , 1994, The Lancet.
[31] E. Barnathan. Has lipoprotein 'little' (a) shrunk? , 1993, JAMA.
[32] P. Ridker,et al. A prospective study of lipoprotein(a) and the risk of myocardial infarction. , 1993, JAMA.
[33] R. Heyka,et al. Lipoprotein(a) Is an Independent Risk Factor for Cardiovascular Disease in Hemodialysis Patients , 1992, Circulation.
[34] G. Thorgeirsson,et al. Predictive value of apolipoproteins in a prospective survey of coronary artery disease in men. , 1992, The American journal of cardiology.
[35] R. Klein,et al. Lack of association between lipoprotein (a) concentrations and coronary heart disease mortality in diabetes: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. , 1992, Metabolism: clinical and experimental.
[36] M. Pike,et al. A prospective study of obesity, lipids, apolipoproteins and ischaemic heart disease in women. , 1992, Atherosclerosis.
[37] J. Huttunen,et al. Lipoprotein (a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants. , 1991, Atherosclerosis.
[38] L. Wilhelmsen,et al. Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men. , 1990, BMJ.
[39] G. Dahlén. Lipoprotein (a) as a risk factor for atherosclerotic diseases. , 1988, Arctic medical research.
[40] M. Blombäck,et al. PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTION , 1987, The Lancet.